Dupilumab Reduces Exacerbations and Improves Lung Function in Patients with Chronic Obstructive Pulmonary Disease and Emphysema: Phase 3 Randomized Trial (BOREAS)
RESPIRATORY MEDICINE（2025）
Key words
COPD,Type 2 inflammation,Eosinophils,Emphysema,Dupilumab,Exacerbations,BMI body mass index
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined